Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Q Sun, Z Hong, C Zhang, L Wang, Z Han… - Signal transduction and …, 2023 - nature.com
Abstract Immune-checkpoint inhibitors (ICBs), in addition to targeting CTLA-4, PD-1, and PD-
L1, novel targeting LAG-3 drugs have also been approved in clinical application. With the …
L1, novel targeting LAG-3 drugs have also been approved in clinical application. With the …
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding
genomic landscapes and biological functions, the treatment of PCa continues to improve …
genomic landscapes and biological functions, the treatment of PCa continues to improve …
Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
The accumulation of senescent cells is a major cause of age-related inflammation and
predisposes to a variety of age-related diseases. However, little is known about the …
predisposes to a variety of age-related diseases. However, little is known about the …
Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
X Zeng, G Liao, S Li, H Liu, X Zhao, S Li, K Lei… - Hepatology, 2023 - journals.lww.com
Conclusions: Our study sheds light on the pivotal role of METTL1 in modulating an
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …
Lysine catabolism reprograms tumour immunity through histone crotonylation
Cancer cells rewire metabolism to favour the generation of specialized metabolites that
support tumour growth and reshape the tumour microenvironment,. Lysine functions as a …
support tumour growth and reshape the tumour microenvironment,. Lysine functions as a …
Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity
L Fang, Y Hao, H Yu, X Gu, Q Peng, H Zhuo, Y Li, Z Liu… - Cancer Cell, 2023 - cell.com
Summary Cyclic GMP-AMP synthase (cGAS) is the major sensor for cytosolic DNA and
activates type I interferon signaling and plays an essential role in antitumor immunity …
activates type I interferon signaling and plays an essential role in antitumor immunity …
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression
Metastasis is the major cause of cancer-related deaths due to the lack of effective therapies.
Emerging evidence suggests that certain epigenetic and transcriptional regulators drive …
Emerging evidence suggests that certain epigenetic and transcriptional regulators drive …
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
ML Jin, KW Jeong - Experimental & Molecular Medicine, 2023 - nature.com
The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of
currently available anticancer therapies. Recent studies have shown that epigenetic …
currently available anticancer therapies. Recent studies have shown that epigenetic …
Asymmetric distribution of parental H3K9me3 in S phase silences L1 elements
In eukaryotes, repetitive DNA sequences are transcriptionally silenced through histone H3
lysine 9 trimethylation (H3K9me3). Loss of silencing of the repeat elements leads to genome …
lysine 9 trimethylation (H3K9me3). Loss of silencing of the repeat elements leads to genome …
IL-7R licenses a population of epigenetically poised memory CD8+ T cells with superior antitumor efficacy that are critical for melanoma memory
G Micevic, A Daniels, K Flem-Karlsen… - Proceedings of the …, 2023 - National Acad Sciences
Recurrence of advanced melanoma after therapy is a major risk factor for reduced survival,
and treatment options are limited. Antitumor immune memory plays a critical role in …
and treatment options are limited. Antitumor immune memory plays a critical role in …